Evidence map›Paper›PMID 27338799›Full record

ArticleBiochemical pharmacology2016

An engineered heterodimeric model to investigate SULT1B1 dependence on intersubunit communication.

Zachary E Tibbs, Charles N Falany

Abstract read
In one paragraph

Article in Biochemical pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Zachary E TibbsThe Department of Pharmacology and Toxicology, The University of Alabama at Birmingham School of Medicine, Birmingham, AL 35294-0019, United States. Electronic address: ztibbs@uab.edu.
Charles N FalanyThe Department of Pharmacology and Toxicology, The University of Alabama at Birmingham School of Medicine, Birmingham, AL 35294-0019, United States. Electronic address: cfalany@uab.edu.
University of Alabama at Birmingham · US

Funding

HUMAN CYTOSOLIC SULFOTRANSFERASESR01GM038953 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FALANY, CHARLES N · 1992 to 2013
$3.3M
NIGMS NIH HHS R01 GM038953
6 · The paper itself

Abstract

Cytosolic sulfotransferases (SULTs) biotransform small molecules to polar sulfate esters as a means to alter their activities within the body. Understanding the molecular mechanism by which the SULTs perform their function is important for optimizing future therapeutic applications. Recent evidence suggests each SULT isoform acts by a half-site reaction (HSR) mechanism, in which a single SULT dimer subunit is active at any given time. HSR requires communication through the highly conserved KxxxTVxxxE dimerization motif. In this investigation, we sought to test the intersubunit interactions of SULT1B1 as it relates to enzyme activity. We generated two populations of SULT1B1 isoforms that efficiently heterodimerize upon mixing by targeted point mutation of the KxxxTVxxxE motif to KxxxTVxxxK or ExxxTVxxxE. The heterodimer exhibited wildtype-like activity with regard to native size, thermal integrity, PAP affinity, and PAPS Km, therefore serving as a valid model for investigating SULT1B1 dimer subunit interactions. The approach granted control over each independent subunit, permitting mutation of the critical 3'-phosphoadenosine 5'-phosphosulfate (PAPS) binding residue Arg258 and/or the catalytic base His109 in a single subunit of the dimer. Substitution of the dysfunctional subunits for fully active subunits yielded dimeric SULT1B1 with 50% the activity of the fully competent dimer, suggesting SULT1B1 intersubunit communication does not significantly contribute to the isoform's activity. These results are a testament to the unique properties of individual SULT isoforms. The dimerization system described in this manuscript can be used to study subunit interactions in other SULT isoforms as well as proteins in other families.

Indexed as

Cloning, MolecularDimerizationHumansMutagenesisProtein IsoformsProtein SubunitsRecombinant ProteinsSulfotransferasesiodothyronine sulfotransferaseProtein IsoformsProtein SubunitsRecombinant ProteinsSulfotransferasesDrug metabolismHalf-site reactivityProtein engineeringSulfationSULT1B1

Identifiers

PMID27338799
PMCPMC4982705
OpenAlexW2468924486

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.